Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from v3.6.6 to v3.7.0, signaling a new version of the page/document. This reflects an update to the page's metadata rather than to substantive content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5. This update reflects a software/version bump with no visible changes to the page's content or layout.SummaryDifference0.0%

- Check22 days agoChange DetectedA funding attribution for 2017 NIH grant/contract has been added to the study details, indicating NIH support for the trial.SummaryDifference0.0%

- Check36 days agoChange DetectedA new revision tag v3.6.5 was added to the page, and the Plain Language Summary section was removed along with the previous revision tag v3.6.4, indicating a versioning update that alters the accessible summary content.SummaryDifference0.0%

- Check43 days agoChange DetectedNew update dates were added to the study's update history: 2026-07-31, 2026-07-29, and 2026-07, and older dates were removed (2026-07-27, 2026-07-08, 2026-06). These changes reflect recent posting activity and maintenance of the page's update timeline.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire (Site 0209) and Gliwice, Silesian Voivodeship, Poland (44-102) to the locations, while removing the previous CIUSSS de l'Estrie-CHUS entry (Site 0209) and Gliwice 44-101. Renamed/standardized the Charing Cross Hospital site (Site 1603) to reflect the official institutional naming.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.